Rosen Law Firm Encourages Inovio Investors to Secure Counsel Before Deadline

Investors who purchased Inovio securities between October 2023 and December 2025 may be eligible for compensation.

Mar. 16, 2026 at 1:39am

Got story updates? Submit your updates here. ›

The Rosen Law Firm, a global investor rights law firm, is reminding purchasers of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025 of the important April 7, 2026 lead plaintiff deadline in a securities class action lawsuit against the company. The lawsuit alleges that Inovio made false and misleading statements about the manufacturing of its CELLECTRA device and the regulatory prospects of its INO-3107 drug candidate.

Why it matters

This case highlights the importance of investors being aware of potential securities fraud and taking action to protect their rights. The Rosen Law Firm is encouraging affected Inovio investors to join the class action lawsuit, which could lead to compensation without any out-of-pocket fees or costs.

The details

According to the lawsuit, Inovio made false and misleading statements about: (1) manufacturing deficiencies with its CELLECTRA device; (2) the likelihood of Inovio submitting the INO-3107 Biologics License Application (BLA) to the FDA by the second half of 2024; (3) the eligibility of INO-3107 for FDA accelerated approval or priority review; and (4) the overall regulatory and commercial prospects of INO-3107. The lawsuit claims that when the true details entered the market, investors suffered damages.

  • The class period is from October 10, 2023 to December 26, 2025.
  • The lead plaintiff deadline is April 7, 2026.

The players

Rosen Law Firm

A global investor rights law firm that is representing investors in this securities class action lawsuit against Inovio Pharmaceuticals.

Inovio Pharmaceuticals, Inc.

A biopharmaceutical company that is the defendant in this securities class action lawsuit.

Got photos? Submit your photos here. ›

What’s next

To join the Inovio class action, investors can go to the Rosen Law Firm's website or contact the firm for more information. The deadline to move the court to serve as lead plaintiff is April 7, 2026.

The takeaway

This case highlights the importance for investors to be vigilant about potential securities fraud and to take action to protect their rights, such as by joining a class action lawsuit if they have been affected. The Rosen Law Firm is encouraging Inovio investors to secure counsel before the upcoming lead plaintiff deadline.